The two kidney to one kidney transition and transplant glomerulopathy: A podocyte perspective

Journal of the American Society of Nephrology

Volumn 26, Issue 6, 2015, Pages 1450-1465

  Yang, Yan ^a   Hodgin, Jeffrey B ^a   Afshinnia, Farsad ^a   Wang, Su Q ^a   Wickman, Larysa ^b   Chowdhury, Mahboob ^a   Nishizono, Ryuzoh ^a   Kikuchi, Masao ^a   Huang, Yihung ^a   Samaniego, Milagros ^a   Wiggins, Roger C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PODOCIN;

ADULT; ARTICLE; CELL DENSITY; CELL STRESS; CREATININE BLOOD LEVEL; FEMALE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY HYPERTROPHY; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NEPHRECTOMY; PODOCYTE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; ADAPTATION; ADVERSE EFFECTS; ANIMAL; AUTOGRAFT; COMPARATIVE STUDY; DISEASE MODEL; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; METABOLISM; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RAT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANIMALS; AUTOGRAFTS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PODOCYTES; POSTOPERATIVE COMPLICATIONS; RATS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84930423446     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014030287     Document Type: Article

References (41)

1. Wanner N, Hartleben B, Herbach N, Goedel M, Stickel N, Zeiser R, Walz G, Moeller MJ, Grahammer F, Huber TB: Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol 25: 707-716, 2014
2. Kriz W: Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 57: 189-195, 2002
3. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419, 2005
4. Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, Misek DE, Kuick RD, Wiggins RC: Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: Prevention by calorie restriction. J Am Soc Nephrol 16: 2953-2966, 2005
5. Wiggins RC: The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007
6. Fukuda A, Chowdhury MA, Venkatareddy MP, Wang SQ, Nishizono R, Suzuki T, Wickman LT, Wiggins JE, Muchayi T, Fingar D, Shedden KA, Inoki K, Wiggins RC: Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol 23: 1351-1363, 2012
7. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC: Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 20: 1041-1052, 2009
8. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC: Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 81: 40-55, 2012
9. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC: Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005
10. Luyckx VA, Brenner BM: The clinical importance of nephron mass. J Am Soc Nephrol 21: 898-910, 2010
11. Praga M, Hernández E, Herrero JC, Morales E, Revilla Y, Díaz-González R, Rodicio JL: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58: 2111-2118, 2000
12. Giral M, Foucher Y, Karam G, Labrune Y, Kessler M, Hurault de Ligny B, Büchler M, Bayle F, Meyer C, Trehet N, Daguin P, Renaudin K, Moreau A, Soulillou JP: Kidney and recipient weight incompatibility reduces long-term graft survival. J Am Soc Nephrol 21: 1022-1029, 2010
13. Meier-Kriesche H-U, Arndorfer JA, Kaplan B: The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 73: 70-74, 2002
14. Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line P-D, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H: Long-term risks for kidney donors. Kidney Int 86: 162-167, 2014
15. Muzaale AD, Massie AB, Wang M-C, Montgomery RA, McBride MA, Wainright JL, Segev DL: Risk of end-stage renal disease following live kidney donation. JAMA 311: 579-586, 2014
16. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR): OPTN/SRTR 2011 Annual Data Report, Rockville, MD, Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2012
17. Wickman L, Afshinnia F, Wang SQ, Yang Y, Wang F, Chowdhury M, Graham D, Hawkins J, Nishizono R, Tanzer M, Wiggins J, Escobar GA, Rovin B, Song P, Gipson D, Kershaw D, Wiggins RC: Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol 24: 2081-2095, 2013
18. Venkatareddy M, Wang SQ, Yang Y, Patel S, Wickman L, Nishizono R, Chowdhury M, Hodgin J, Wiggoins PA, Wiggins RC: Estimating podocyte number and density in histologic sections. J Am Soc Nephrol 25: 1118-1129, 2014
19. Song T, Fu L, Huang Z, He S, Zhau R, Lin T, Wei Q: Change in renal parenchymal volume in living transplant donors. Int Urol Nephrol 46: 743-747, 2014
20. Agustian PA, Schiffer M, Gwinner W, Schäfer I, Theophile K, Modde F, Bockmeyer CL, Traeder J, Lehmann U, Grosshennig A, Kreipe HH, Bröcker V, Becker JU: Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy. Am J Pathol 178: 2007-2019, 2011
21. Pippin J, Kumar V, Stein A, Jablonski P, Shankland SJ, Davis CL: The contribution of podocytes to chronic allograft nephropathy. Nephron, Exp Nephrol 111: e1-e10, 2009
22. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342-348, 1997
23. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD: Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61: 1475-1485, 2002
24. El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, Cosio FG: Identifying specific causes of kidney allograft loss. Am J Transplant 9: 527-535, 2009
25. Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, DeGoey S, Griffin MD, Larson TS, Cosio FG: Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 7: 2124-2132, 2007
26. Sis B, Campbell PM, Mueller T, Hunter C, Cockfield SM, Cruz J, Meng C, Wishart D, Solez K, Halloran PF: Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 7: 1743-1752, 2007
27. Cosio FG, Gloor JM, Sethi S, Stegall MD: Transplant glomerulopathy. Am J Transplant 8: 492-496, 2008
28. Akalin E, Dinavahi R, Dikman S, de Boccardo G, Friedlander R, Schroppel B, Sehgal V, Bromberg JS, Heeger P, Murphy B: Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2: 1261-1267, 2007
29. Wavamunno MD, O'Connell PJ, Vitalone M, Fung CL, Allen RD, Chapman JR, Nankivell BJ: Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 7: 2757-2768, 2007
30. Haas M, Mirocha J: Early ultrastructural changes in renal allografts: Correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 11: 2123-2131, 2011
31. Amer H, Cosio FG: Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol 20: 2490-2492, 2009
32. Serón D, Burgos D, Alonso A: Histology and proteinuria after renal transplantation. Transplant Rev (Orlando) 26: 20-26, 2012
33. Soler MJ, Riera M, Gutierrez A, Pascual J: New options and perspectives for proteinuria management after kidney transplantation. Transplant Rev (Orlando) 26: 44-52, 2012
34. Ibrahim HN, Jackson S, Connaire J, Matas A, Ney A, Najafian B, West A, Lentsch N, Ericksen J, Bodner J, Kasiske B, Mauer M: Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 24: 320-327, 2013
35. Rovira J, Arellano EM, Carreras J, Campos B, Vodenik B, Bañón-Maneus E, Ramírez-Bajo MJ, Moya-Rull D, Solé-González A, Hernández A, Revuelta I, Quintana LF, Howat WJ, Campistol JM, Diekmann F: Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction. Transplantation 88: 646-652, 2009
36. Paoletti E, Ratto E, Bellino D, Marsano L, Cassottana P, Cannella G: Effect of early conversion from CNI to sirolimus on outcomes in kidney transplant recipients with allograft dysfunction. J Nephrol 25: 709-718, 2012
37. Hernández D, Martínez D, Gutiérrez E, López V, Gutiérrez C, García P, Cobelo C, Cabello M, Burgos D, Sola E, González-Molina M: Clinical evidence on the use of anti-mTOR drugs in renal transplantation. Nefrologia 31: 27-34, 2011
38. Haas M, Sis B, Racusen L, Solez K, Glotz D, Colvin R, Castro M, David D, David-Neto E, Bagnasco S, Cendales L, Cornell L, Demetris A, Drachenberg C, Farver C, Farris A 3rd, Gibson I, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez E, Rush D, Smith RN, Tan C, Wallace W, Mengel M; Banff Meeting Report Writing Committee: Banff 2013 Meeting Report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transpl 14: 272-283, 2014
39. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7: 518-526, 2007
40. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
41. Weibel ER: Stereologic Methods: Practical Methods for Biologic Morphometry, London, Academic Press Inc, 1979, pp 40-116, 415